CORE LABORATORIES INC (CLB)
US21867A1051 - Common Stock
CLB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 65 industry peers in the Energy Equipment & Services industry. Both the profitability and the financial health of CLB get a neutral evaluation. Nothing too spectacular is happening here. CLB is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CLB was profitable.
In the past year CLB had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLB reported negative net income in multiple years.
Of the past 5 years CLB 4 years had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 6.26%, CLB is doing good in the industry, outperforming 66.15% of the companies in the same industry.
CLB's Return On Equity of 16.32% is fine compared to the rest of the industry. CLB outperforms 80.00% of its industry peers.
CLB has a Return On Invested Capital of 8.97%. This is in the better half of the industry: CLB outperforms 67.69% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLB is in line with the industry average of 7.69%.
The 3 year average ROIC (7.69%) for CLB is below the current ROIC(8.97%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.26% | ||
| ROE | 16.32% | ||
| ROIC | 8.97% |
ROA(3y)4.34%
ROA(5y)1.8%
ROE(3y)13.16%
ROE(5y)-7.94%
ROIC(3y)7.69%
ROIC(5y)8.82%
1.3 Margins
The Profit Margin of CLB (7.20%) is better than 63.08% of its industry peers.
In the last couple of years the Profit Margin of CLB has declined.
Looking at the Operating Margin, with a value of 11.27%, CLB is in the better half of the industry, outperforming 63.08% of the companies in the same industry.
In the last couple of years the Operating Margin of CLB has declined.
CLB has a Gross Margin of 21.54%. This is in the lower half of the industry: CLB underperforms 61.54% of its industry peers.
CLB's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.27% | ||
| PM (TTM) | 7.2% | ||
| GM | 21.54% |
OM growth 3Y-2.8%
OM growth 5Y-8.16%
PM growth 3YN/A
PM growth 5Y-8.71%
GM growth 3Y-2.28%
GM growth 5Y-5.83%
2. Health
2.1 Basic Checks
CLB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
There is no outstanding debt for CLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 3.65 indicates that CLB is not in any danger for bankruptcy at the moment.
CLB has a Altman-Z score of 3.65. This is amongst the best in the industry. CLB outperforms 81.54% of its industry peers.
The Debt to FCF ratio of CLB is 11.48, which is on the high side as it means it would take CLB, 11.48 years of fcf income to pay off all of its debts.
CLB has a Debt to FCF ratio of 11.48. This is comparable to the rest of the industry: CLB outperforms 41.54% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that CLB is somewhat dependend on debt financing.
CLB has a worse Debt to Equity ratio (0.73) than 67.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 11.48 | ||
| Altman-Z | 3.65 |
ROIC/WACC1.06
WACC8.43%
2.3 Liquidity
A Current Ratio of 2.53 indicates that CLB has no problem at all paying its short term obligations.
CLB has a better Current ratio (2.53) than 69.23% of its industry peers.
A Quick Ratio of 1.72 indicates that CLB should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.72, CLB is doing good in the industry, outperforming 66.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.53 | ||
| Quick Ratio | 1.72 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.13% over the past year.
The earnings per share for CLB have been decreasing by -14.36% on average. This is quite bad
EPS 1Y (TTM)5.13%
EPS 3Y4.92%
EPS 5Y-14.36%
EPS Q2Q%4.76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.11%
3.2 Future
CLB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.82% yearly.
CLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.40% yearly.
EPS Next Y99.37%
EPS Next 2Y40.16%
EPS Next 3Y17.29%
EPS Next 5Y14.82%
Revenue Next Year15.68%
Revenue Next 2Y6.32%
Revenue Next 3Y3.77%
Revenue Next 5Y3.4%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
CLB is valuated quite expensively with a Price/Earnings ratio of 29.48.
CLB's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 24.41. CLB is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 14.78, CLB is valued correctly.
Based on the Price/Forward Earnings ratio, CLB is valued a bit more expensive than the industry average as 63.08% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of CLB to the average of the S&P500 Index (20.59), we can say CLB is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.48 | ||
| Fwd PE | 14.78 |
4.2 Price Multiples
84.62% of the companies in the same industry are cheaper than CLB, based on the Enterprise Value to EBITDA ratio.
67.69% of the companies in the same industry are cheaper than CLB, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 79.77 | ||
| EV/EBITDA | 17.61 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLB's earnings are expected to grow with 17.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y40.16%
EPS Next 3Y17.29%
5. Dividend
5.1 Amount
CLB has a yearly dividend return of 0.18%, which is pretty low.
Compared to an average industry Dividend Yield of 3.04, CLB has a dividend in line with its industry peers.
With a Dividend Yield of 0.18, CLB pays less dividend than the S&P500 average, which is at 2.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.18% |
5.2 History
The dividend of CLB decreases each year by -73.70%.
CLB has paid a dividend for at least 10 years, which is a reliable track record.
CLB has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-73.7%
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
5.09% of the earnings are spent on dividend by CLB. This is a low number and sustainable payout ratio.
DP5.09%
EPS Next 2Y40.16%
EPS Next 3Y17.29%
CORE LABORATORIES INC
NYSE:CLB (7/26/2024, 7:22:24 PM)
After market: 24.17 0 (0%)24.17
-0.18 (-0.74%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.13B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.18% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.48 | ||
| Fwd PE | 14.78 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.3
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.26% | ||
| ROE | 16.32% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 11.27% | ||
| PM (TTM) | 7.2% | ||
| GM | 21.54% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.87
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.53 | ||
| Quick Ratio | 1.72 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)5.13%
EPS 3Y4.92%
EPS 5Y
EPS Q2Q%
EPS Next Y99.37%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y